Anti-Beta-2 Microglobulin Antibody Clone SPM617

$ 298.00
Please Select Product Options Below To View The Catalog Number.

SKU: 567-MSM2X
Species: Human and non-human primates
Tested Applications: Flow Cytometry, Immunofluorescence, Immunohistochemistry (IHC)
Available Conjugates: Unconjugated
Isotype: Mouse IgG1 kappa
Mass Spec Validated?: Not MS Validated

Product NumberDescriptionPrice
567-MSM2X-P1 Size: 100 ug, Tag: Unconjugated
Shipping Information
In Stock.
Flat Rate Shipping Anywhere in the US: $45
Datasheets and Documentation
Product Datasheet
Certificate of Analysis and Tags (Coming Soon)
Lot Number:

Expiration Date:

Concentration (Write Lyophilized if Lyophilized):

Reconsitution Instructions (Leave Blank if Liquid):

Manufacture Date:

Purity:

Bioactivity (test results eg. IU/ml):


SKU: 567-MSM2X-P1
Beta-2 Microglobulin General Information
Alternate Names
?2 microglobulin, B2M, B2 microglobulin
Molecular Weight
12kDa
Chromosomal Location
15q21-q22.2
Curated Database and Bioinformatic Data
Gene SymbolB2M
Entrez Gene ID567
Ensemble Gene IDENSG00000166710
RefSeq Protein Accession(s)NP_004039, XP_005254606
RefSeq mRNA Accession(s)NM_004048, XM_005254549,
RefSeq Genomic Accession(s)NC_018926, NC_000015, NG_187605, NG_012920
UniProt ID(s)Q9UDF4, P01884, P61769
UniGene ID(s)Q9UDF4, P01884, P61769
HGNC ID(s)914
Cosmic ID(s)B2M
KEGG Gene ID(s)hsa:567
PharmGKB ID(s)PA25207
General Description of Beta-2 Microglobulin.
Beta2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation,, infection. Increased serum levels are also seen in B-cell malignancies, in renal failure, may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours, autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy).

Human and non-human primates Anti-Beta-2 Microglobulin Antibody Product Attributes

Species: Human and non-human primates
Tested Applications: Flow Cytometry, Immunofluorescence, Immunohistochemistry (IHC).
Application Notes: Flow Cytometry (0.5-1ug of antibody/million cells in 0.1ml), Immunofluorescence (0.5-1ug of antibody/ml), Immunohistochemistry (IHC) (Formalin-fixed) (0.5-1ug of antibody/ml for 30 minutes at RT)
Clonality: Monoclonal
Anti-Beta-2 Microglobulin Antibody Clone: SPM617
Clone SPM617 Host and Isotype: Mouse IgG1 kappa
Anti-Human and non-human primates Beta-2 Microglobulin Positive Control Sample: HL-60 or HeLa cells. Melanomas, Lymphoma. Carcinoma of Stomach, Cervix, Endometrial, Kidney or Colon.
Cellular Localization of Antibody Cell Surface, Extracellular (Secreted)
Buffer and Stabilizer: 10mM PBS with 0.05% BSA & 0.05% azide.
Antibody Concentration: 200ug/ml
Antibody Purification Method:Protein A/G Purified
Immunogen: Full length recombinant human B2M protein
Storage Conditions: Store at 2 to 8° C (refrigerate). Stable for 24 months when properly stored.

Beta-2 Microglobulin Previously Observed Antibody Staining Patterns

Observed Subcellular, Organelle Specific Staining Data:

Anti-B2M antibody staining is expected to be primarily localized to the cytosol, golgi apparatus and plasma membrane.

Observed Antibody Staining Data By Tissue Type:

Variations in Beta-2 Microglobulin antibody staining intensity in immunohistochemistry on tissue sections are present across different anatomical locations. An intense signal was observed in cells in the white pulp in spleen, germinal center cells in the lymph node and tonsil, hematopoietic cells in the bone marrow, macrophages in lung, non-germinal center cells in the lymph node and tonsil, pneumocytes in lung, respiratory epithelial cells in the bronchus and nasopharynx and squamous epithelial cells in the tonsil. More moderate antibody staining intensity was present in cells in the white pulp in spleen, germinal center cells in the lymph node and tonsil, hematopoietic cells in the bone marrow, macrophages in lung, non-germinal center cells in the lymph node and tonsil, pneumocytes in lung, respiratory epithelial cells in the bronchus and nasopharynx and squamous epithelial cells in the tonsil. Low, but measureable presence of Beta-2 Microglobulin could be seen inadipocytes in breast and mesenchymal tissue, bile duct cells in the liver, cells in the granular layer in cerebellum, cells in the molecular layer in cerebellum, cells in the seminiferous ducts in testis, chondrocytes in mesenchymal tissue, exocrine glandular cells in the pancreas, fibroblasts in skin and mesenchymal tissue, glandular cells in the breast and parathyroid gland, glial cells in the caudate nucleus, cerebral cortex and hippocampus, hepatocytes in liver, myocytes in heart muscle and skeletal muscle, myoepithelial cells in the breast, neuronal cells in the caudate nucleus, cerebral cortex and hippocampus, ovarian stroma cells in the ovary, peripheral nerve in mesenchymal tissue, peripheral nerve/ganglion in colon, Purkinje cells in the cerebellum, smooth muscle cells in the smooth muscle, squamous epithelial cells in the cervix and uterine and vagina. We were unable to detect Beta-2 Microglobulin in other tissues. Disease states, inflammation, and other physiological changes can have a substantial impact on antibody staining patterns. These measurements were all taken in tissues deemed normal or from patients without known disease.

Observed Antibody Staining Data By Tissue Disease Status:

Tissues from cancer patients, for instance, have their own distinct pattern of Beta-2 Microglobulin expression as measured by anti-Beta-2 Microglobulin antibody immunohistochemical staining. The average level of expression by tumor is summarized in the table below. The variability row represents patient to patient variability in IHC staining.

Sample Type breast cancer carcinoid cervical cancer colorectal cancer endometrial cancer glioma head and neck cancer liver cancer lung cancer lymphoma melanoma ovarian cancer pancreatic cancer prostate cancer renal cancer skin cancer stomach cancer testicular cancer thyroid cancer urothelial cancer
Signal Intensity + - + ++ + - + ++ - ++ + + + + + - ++ - ++ +
B2M Variability +++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ + ++ +++

Limitations and Warranty

enQuire Bio's Beta-2 Microglobulin Anti-Human, Primate Monoclonal is available for Research Use Only. This antibody is guaranteed to work for a period of two years when properly stored.

There are no reviews yet.

Be the first to review “Anti-Beta-2 Microglobulin Antibody Clone SPM617”

Your email address will not be published. Required fields are marked *

Share a Protocol (View Reviewed Protocols Below)

Protocol Title

Materials

Methods

Notes


  protocol submission gif
enQuire Bio, LLC   8420 S Continental Divide Rd, #202   Littleton, CO 80127
Phone: 1-855-344-1400 | enquire@enquirebio.com | Fax: 1-720-897-3730
Customer Service Available M-F 8AM-6PM MST or 24/7 Via Email

Anti-Beta-2 Microglobulin Antibody Clone SPM617

https://enquirebio.com/wp-content/uploads/2019/01/Beta-2 Microglobulin IHC human Cervical Carcinoma (SPM617)-300x225.jpg